675 684
Deferred tax assets 781 190 28
Total assets 952,918 1,003,347 146,899
Liabilities
Current liabilities
Accounts payable 1,939 3,199 468
Deferred grant income 374 374 55
Accrued expenses and other payables 25,273 27,072 3,964
Income tax payable 1,256 3,127 458
Other current liabilities 57 -- --
Total current liabilities 28,899 33,772 4,945
Deferred grant income 3,152 2,965 434
Other liabilities 472 -- --
Total liabilities 32,523 36,737 5,379
Commitments and contingencies -- -- --
Shareholders' equity
Share capital -ordinary shares
US$0.0001 par value, 500,000,000
shares authorized, 150,575,955 and
150,586,455 issued and outstanding
as of December 31, 2008 and June 30,
2009, respectively. 121 121 18
Additional paid-in capital 908,377 910,271 133,272
Accumulated other comprehensive loss (102,126) (100,669) (14,740)
Retained earnings 114,023 156,887 22,970
To Total shareholders' equity 920,395 966,610 141,520
Total liabilities and shareholders'
equity 952,918 1,003,347 146,899
3SBio Inc. and subsidiaries
Unaudited quarterly consolidated statements of income
(expressed in thousands, except per share , per ADS and other share and
AD
'/>"/>SOURCE 3SBio Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Related medicine news :1.
3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 20092.
3SBio Inc. Announces Unaudited First Quarter 2009 Results3.
3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP4.
3SBio Inc. Announces Filing of Annual Report on Form 20-F5.
3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference6.
Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results7.
Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors8.
Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction9.
Leading Medical Developer Announces Plans for Texoma Medical Plaza10.
iMedX Announces Investment of $13M From RFE Investment Partners11.
Health Market Science Announces Commercial Release of CompleteSpend V2.5